The Asian Pacific Association for the Study of the Liver [APASL]

Year City President Topic APASL Designated Conference
2006 (1st) Calcutta Dr. YK Chawla Hepatic Fibrosis-Basic Science to Therapy
2007 (2nd) Pattaya Dr. C Pramoolsinsap The Innovation in Chronic Hepatitis B Treatment 1st APASL HBV Conference
2008 (3rd) Cairo Dr. G Shiha
Dr. A Ibrahim
Liver Fibrosis 1st APASL Liver Fibrosis Conference
2008 (4th) Bali Dr. L Lesmana Hepatocellular Carcinoma 1st APASL HCC Conference
2009 (5th) Istanbul Dr. AK Dökmeci Non Responders
2009 (6th) Karachi Dr. S Hamid
Dr. W Jafri
Acute Liver Failure : Asian-Pacfic Perspectives 1st APASL ACLF Conference
2010 (7th) Chiba Dr. O Yokosuka HCV 1st APASL HCV Conference
2011 (8th) Beijing Dr. FS Wang Hepatitis B Virus 2nd APASL HBV Conference
2011 (9th) Jeju Dr. BC Yoo Hepatocellular Carcinoma 2nd APASL HCC Conference
2012 (10th) Ulaan baatar Dr. A Jazag HBV & HCV Dual Infection 2nd APASL HCV Conference
2012 (11th) Dhaka Dr. S Rahman HBV 3rd APASL HBV Conference
2013 (12th) Cebu Dr. D Payawal HCC 3rd APASL HCC Conference
2013 (13th) Jakarta Dr. R Gani NASH 1st APASL NASH Conference
2014 (14th) Cairo Dr. G Shiha Liver Fibrosis 2nd APASL Liver Fibrosis Conference
2014 (15th) Karachi Dr. Z Abbas HCV 3rd APASL HCV Conference
2014 (16th) Guangzhou Dr. JL Hou HBV 4th APASL HBV Conference
2015 (17th) Yerevan Dr. H Ghazinyan HBV 5th APASL HBV Conference
2015 (18th) New Delhi Dr. BC Sharma HCV 4th APASL HCV Conference
2016 (19th) Busan Dr. KH Han Liver Cirrhosis 1st APASL Liver Cirrhosis Conference
2016 (20th) Kaohsiung Dr. WL Chuang HCV 5th APASL HCV Conference
2016 (21st) Beijing Dr. Lai Wei HBV 6th APASL HBV Conference
2017 (22nd) Nagasaki Dr. Hiroshi Yatsuhashi HCC 4th APASL HCC Conference
2017 (23rd) Ulaanbaatar Dr. Oidov Baatarkhuu HCV and coinfection 6th APASL HCV Conference
2017 (24th) Cairo Dr. Gamal Shiha HCV 7th APASL HCV Conference
2018 (25th) Yokohama Dr. Shuichiro Shiina HCC 5th APASL HCC Conference
2018 (26th) Taipei Dr. Rong-Nan Chien HBV in Asia-Pacific 7th APASL HBV Conference
2018 (27th) Kuala Lumpur Dr. Rosmawati Mohamed HCV 8th APASL HCV Conference
2018 (28th) Istanbul Dr. Necati Ormeci Non-Responder
2018 (29th) Beijing Dr. Gui-Qiang Wang Autoimmune
2019 (30th) Tokyo Dr. Atsushi Tanaka Liver Immunology and Genetics
2019 (31st) Baku Dr. Gulnara Aghayeva Hepatitis Delta
2020 (32nd) Guangzhou Dr. Xiaolong Qi Portal Hypertension
2021 (33rd) Osaka Dr. Norifumi Kawada Molecular and Cellular Biology
2021 (34th) Tokyo Dr. Mitsuhiko Moriyama Oncology 1st APASL 2020 Oncology
6th APASL HCC Conference
2022 (35th) Beijing Dr. Hong You Liver Fibrosis
2022 (36th) Taipei Dr. Chun-Jen Liu Paradigm Shift of HCC Management: Across Viral to Steatogenic Carcinogenesis
2022 (37th) Cairo Dr. Gamal Shiha Liver Fibrosis: Liver Fibrosis in the era of MAFLD
2022 (38th) Takamatsu Dr. Tsutomu Masaki HCC:Clinical and basic research
2022 (39th) Wuhan Dr. Qin Ning Critical Care in Hepatology ACLF
2022 (40th) Istanbul Dr. Ibrahim Halil Bahcecioglu Hepatotoxicity
2022 (41st) Yerevan Dr. Hasmik Ghazinian NAFLD/NASH: Non-Infection Epidemic in XXI
2022 (42nd) Guangzhou Dr. Jinjun Chen Image-guided Interventions in Liver Diseases
2023 (43rd) Manila Dr. Ian Homer Y. Cua Liver Cirrhosis and Its Complication
2023 (44th) Busan Dr. Si Hyun Bae Viral Hepatitis
2023 (45th) Sendai Dr. Yoshiyuki Ueno Oncology
2024 (46th) Kaohsiung Dr. Ming Lung Yu Metabolic Disorders
2024 (47th) Chiba Dr. Naoya Kato Genomics Meets Immunology
2024(48th) Bali Dr. Cosmas Rinaldi A. Lesmana New Concept of Portal Hypertension and Hepatobiliary Malignancy related
2024 (49th) AlmatyDr. Alexander NersesovLiver Cirrhosis: Common and Rare Complications
2025 (50th)MumbaiDr. Akash ShuklaImproving Non-transplant Outcomes in Patients with Advanced Liver Disease
2025 (51st)IstanbulDr. Vedat GoralLiver Cirrhosis: Current and New Therapies
2025 (52nd)QingdaoDr. Jinzhen CaiFull Process Management of Liver Transplant Patients
2025 (53rd)TashkentDr. Musabaev ErkinViral Hepatitis Elimination by 2030: Progress and Challenges
2025 (54th)TaipeiDr. Yi-Hsiang HuangOncology-Multifaceted Approach and Treatment for Liver Cancer
2025 (55th)MoscowDr. Andrey KostinAlcoholic Liver Disease3rd APASL NASH Conference
2025 (56th)TokyoDr. Kenichi IkejimaNew Horizons for Steatotic Liver Disease: Cutting Edge Research and Emerging Therapeutics4th APASL NASH Conference
2025 (57th)YangonDr. Kyaw Soe TunCurrent Management of HCC with Local Relevance11th APASL HCC Conference
2025 (58th)KarachiDr. Amna Subhaan ButtMAFLD and Metabolic Complications: Applying Multidisciplinary Solutions5th APASL NASH Conference